Stratifying patients based on IDH mutation suggested no association of PTMA expression with patient survival in either IDH wildtype (Supplementary Figure S3E–H) or IDH mutant glioma (Supplementary Figure S3I–L), suggesting that prognostic association of PTMA with patient survival is likely to be dependent upon the IDH mutation status. The gene discussed is IDH1; the disease is central nervous system cancer.